Volume 114, Nº 1, January 2020
DOI: https://doi.org/10.36660/abc.20190111
REVIEW ARTICLE
Pathophysiology and Treatment of Heart Failure with Preserved Ejection Fraction: State of the Art and Prospects for the Future
Sara Lopes Fernandes
Rita Ribeiro Carvalho
Luís Graça Santos
Fernando Montenegro Sá
Catarina Ruivo
Sofia Lázaro Mendes
Hélia Martins
João Araujo Morais
Figure 1 – Pathophysiology of HFpEF - possible mechanisms involved. AF: atrial fibrillation; CAD: coronary artery disease; CKD: chronic kidney disease; COPD: chronic obstructive pulmonary disease; HFpEF: heart failure with preserved ejection fraction; HT: arterial hypertension; NO-cGMP-PKG: nitric oxide, reduced cyclic guanosine monophosphate and protein kinase G; PH: pulmonary hypertension; RAAS: renin-angiotensin-aldosterone system; RV: right ventricle.
Keywords: Heart Failure/physiopathology; Heart Failure/diagnosis; Heart Failure/drug therapy; Systolic Volume; Heart Failure/ complications.